MassDevice Q&A: Covidien medical devices president José Almeida

January 11, 2010 by Brad Perriello

Covidien's medical devices division president on reviving the company after its spinout from Tyco Healthcare and how it turned around in a down economy.

MassDevice Q&A: Covidien medical devices president Joe Almeida

José Almeida knows what it takes to succeed. The native of Brazil, a mechanical engineer by training, put down roots in the U.S. 20 years ago and never looked back.

Since then he's worked his way up the corporate ladder at firms including Acufex Microsurgical, Johnson & Johnson (NYSE:JNJ), Greatbatch Technologies and Tyco Healthcare. When the latter spun out into Covidien in late June, 2007, Almeida had been in his current role for a year already after spending the better part of 12 years with the company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Features

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Transcend Medical CEO Brian Walsh tells MassDevice.com why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Integrity Applications looks beyond optical sensors with its GlucoTrack Model DF-F, which uses ultrasonic, electromagnetic and thermal technology to measure physiological changes associated with blood glucose levels.

Former NBA player Jonathan Bender tries his hand at entrepreneurship, aiming to bring the physical therapy device he invented to the U.S. market.

Battelle engineering manager Melissa Masters tells MassDevice.com how insights ranging from national security to aeronautics can inform the creation of disruptive new medical devices.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp